| Date | Form | Description | Docs | XBRL | Pages |
| 02/10/11 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 02/10/11 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 02/10/11 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 01/31/11 | NT 10-K | Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10KT |
|
4 | |
| 12/14/10 | 8-K | Current report filing |
|
2 | |
| 12/10/10 | 5 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 12/10/10 | 5 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 09/29/10 | CORRESP | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. |
|
3 | |
| 09/28/10 | UPLOAD | SEC-generated letter |
|
2 | |
| 09/27/10 | DEF 14A | Definitive proxy statements |
|
21 |
Latest News & Events
Anixa Biosciences to Present at the Spartan Capital Securities Second Annual Investor Conference
Read More...Anixa Biosciences Announces Issuance of Chinese Patent Covering Breast Cancer Vaccine Technology
Read More...Anixa Biosciences Announces Completion of Final Patient Visit in Breast Cancer Vaccine Clinical Trial
Read More...